Arthrone Technology Closes RMB 100 Million Series C Financing

August 25, 2023 China, Financing

Beijing-based Arthrone Technology closes RMB 100 million ($13.6 million) Series C financing led by SAIF Partners and followed by CDIB Capital International, to accelerate the commercialization of ceramic joint products and the development of a pipeline of follow-on products.

Founded in 2017, Arthrone Technology is the only joint enterprise in China that has mastered the production technology of both zirconia and alumina ceramic materials at the same time, in which the zirconia ceramic ball head has formally entered the special approval procedure for innovative medical devices of China’s National Medical Products Administration (NMPA).

Ceramic ball head is the core component of artificial joints, but there is only one overseas supplier in the Chinese market at present, according to Mr. Jifeng Zhang, Chairman of Arthrone Technology.

Based on the unique patented technology and strict production quality control process, the performance of Arthrone Technology’s zirconia ceramic joints is better than imported products and has a great cost advantage, providing Chinese patients with more cost-effective and excellent domestic ceramic joints.

The Post is Available in: English – 简体中文